Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M N Dudley

Showing results (11-20 of 67) with videos related to

Pageof 7
Sort By:
Pediatric Infectious Disease|September 1, 1985
Clinical pharmacology of benzathine penicillin GG Peter, M N Dudley
The Journal of Antimicrobial Chemotherapy|August 4, 1998
Beta-lactam/beta-lactamase inhibitor combinations: pharmacodynamic considerations and possible role in the management of bacterial infections in the neutropenic hostC Okereke, M N Dudley
American Journal of Hospital Pharmacy|January 1, 1981
Antimicrobial irrigations in the prevention and treatment of catheter-related urinary tract infectionsM N Dudley, S L Barriere
Pharmacotherapy|August 24, 1999
Intracellular phosphorylation of zidovudine in an in vitro hollow fiber modelK Z Rana, M N Dudley
The Journal of Antimicrobial Chemotherapy|May 1, 1991
Single daily dosing of amikacin in an in-vitro modelM N Dudley, S H Zinner
Diagnostic Microbiology and Infectious Disease|May 1, 1997
Microbiologic and pharmacodynamic principals applied to the antimicrobial susceptibility testing of ampicillin/sulbactam: analysis of the correlations between in vitro test results and clinical responseR N Jones, M N Dudley
American Journal of Hospital Pharmacy|February 1, 1990
Potential effect of oral antimicrobial therapy on nurse staffing requirementsL L Lincoln, M N Dudley
Current Opinion in Microbiology|October 26, 2000
Pharmacodynamics in the study of drug resistance and establishing in vitro susceptibility breakpoints: ready for prime timeM N Dudley, P G Ambrose
Clinical Pharmacy|March 1, 1982
Cefotaxime: microbiology, pharmacology, and clinical useM N Dudley, S L Barriere
Pharmacotherapy|January 23, 1999
Human immunodeficiency virus protease inhibitorsK Z Rana, M N Dudley
Pageof 7

Showing results (11-20 of 67) with videos related to

Sort By:
Pageof 7
Pediatric Infectious Disease|September 1, 1985
Clinical pharmacology of benzathine penicillin GG Peter, M N Dudley
The Journal of Antimicrobial Chemotherapy|August 4, 1998
Beta-lactam/beta-lactamase inhibitor combinations: pharmacodynamic considerations and possible role in the management of bacterial infections in the neutropenic hostC Okereke, M N Dudley
American Journal of Hospital Pharmacy|January 1, 1981
Antimicrobial irrigations in the prevention and treatment of catheter-related urinary tract infectionsM N Dudley, S L Barriere
Pharmacotherapy|August 24, 1999
Intracellular phosphorylation of zidovudine in an in vitro hollow fiber modelK Z Rana, M N Dudley
The Journal of Antimicrobial Chemotherapy|May 1, 1991
Single daily dosing of amikacin in an in-vitro modelM N Dudley, S H Zinner
Diagnostic Microbiology and Infectious Disease|May 1, 1997
Microbiologic and pharmacodynamic principals applied to the antimicrobial susceptibility testing of ampicillin/sulbactam: analysis of the correlations between in vitro test results and clinical responseR N Jones, M N Dudley
American Journal of Hospital Pharmacy|February 1, 1990
Potential effect of oral antimicrobial therapy on nurse staffing requirementsL L Lincoln, M N Dudley
Current Opinion in Microbiology|October 26, 2000
Pharmacodynamics in the study of drug resistance and establishing in vitro susceptibility breakpoints: ready for prime timeM N Dudley, P G Ambrose
Clinical Pharmacy|March 1, 1982
Cefotaxime: microbiology, pharmacology, and clinical useM N Dudley, S L Barriere
Pharmacotherapy|January 23, 1999
Human immunodeficiency virus protease inhibitorsK Z Rana, M N Dudley
Pageof 7